123 related articles for article (PubMed ID: 2568303)
21. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
Cavanagh RL; Buyniski JP
Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
[TBL] [Abstract][Full Text] [Related]
22. Effects of histamine H2 receptor antagonists on acid secretion stimulated by imidazoline derivatives in isolated parietal cells.
Houi N; Kamisaki Y; Itoh T
Eur J Pharmacol; 1987 Nov; 144(1):67-76. PubMed ID: 2449355
[TBL] [Abstract][Full Text] [Related]
23. Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells.
Sewing KF; Hannemann H
Pharmacology; 1986; 33(5):274-8. PubMed ID: 2432626
[TBL] [Abstract][Full Text] [Related]
24. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
Stables R; Humphray JM; Reeves JJ
Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
Gladziwa U; Wagner S; Sieberth HG; Klotz U
Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dog.
Stables R; Daly MJ; Humphray JM
Agents Actions; 1983 Apr; 13(2-3):166-9. PubMed ID: 6135321
[TBL] [Abstract][Full Text] [Related]
27. Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.
Tsai BS; Kessler LK; Butchko GM; Bauer RF
Dig Dis Sci; 1987 Sep; 32(9):1010-6. PubMed ID: 3040357
[TBL] [Abstract][Full Text] [Related]
28. A histamine H2 receptor antagonist, roxatidine, stimulates mucus secretion and synthesis by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Physiol Pharmacol; 1995 Dec; 46(4):503-11. PubMed ID: 8770793
[TBL] [Abstract][Full Text] [Related]
29. P1(A2/Ra)-purinoceptors may mediate the stimulatory effect of adenosine and adenosine analogs on acid formation in isolated rabbit parietal cells.
Ainz LF; Salgado C; Gandarias JM; Gomez R; Vallejo A; Gil-Rodrigo CE
Pharmacol Res; 1993; 27(4):319-34. PubMed ID: 8103595
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.
Black JW; Leff P; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):589-99. PubMed ID: 2866003
[TBL] [Abstract][Full Text] [Related]
31. PACAP stimulates gastric acid secretion in the rat by inducing histamine release.
Sandvik AK; Cui G; Bakke I; Munkvold B; Waldum HL
Am J Physiol Gastrointest Liver Physiol; 2001 Oct; 281(4):G997-G1003. PubMed ID: 11557520
[TBL] [Abstract][Full Text] [Related]
32. Adrenaline stimulates acid production in isolated pig and human parietal cells.
Song YH; Mårdh S; Nyrén O; Lööf L
Scand J Gastroenterol; 1988 Jan; 23(1):35-41. PubMed ID: 2894072
[TBL] [Abstract][Full Text] [Related]
33. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
35. Effects of combined use of roxatidine and pirenzepine on gastric secretion in humans.
Misawa T; Chijiiwa Y; Yoshida K; Tanaka A; Kabemura T; Fujishima H; Harada N; Nawata H
Fukuoka Igaku Zasshi; 1990 Jul; 81(7):242-6. PubMed ID: 1976580
[TBL] [Abstract][Full Text] [Related]
36. Continuing development of acid pump inhibitors: site of action of pantoprazole.
Shin JM; Besancon M; Prinz C; Simon A; Sachs G
Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of action of antisecretory drugs. Studies on isolated canine fundic mucosal cells.
Soll AH
Scand J Gastroenterol Suppl; 1986; 125():1-8. PubMed ID: 2881344
[TBL] [Abstract][Full Text] [Related]
38. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Palacios B; Montero MJ; Sevilla MA; Román LS
Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological profile of mifentidine: a novel H2-receptor antagonist.
Giachetti A; Pagani F; Micheletti R; Brambilla A; Cereda E; Donetti A
Agents Actions; 1985 Apr; 16(3-4):173-5. PubMed ID: 2861730
[TBL] [Abstract][Full Text] [Related]
40. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.
Chiverton SG; Burget DW; Hunt RH
Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
